pasteurised human antihepatitis b immunoglobulin grifols injekčn - søkeresultat

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

human albumin grifols 20%/50ml

grifols malaysia sdn. bhd. - albumin human -

lemtrada

sanofi israel ltd - alemtuzumab - concentrate for solution for infusion - alemtuzumab 12 mg / 1.2 ml - alemtuzumab - lemtrada is indicated as a single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: • patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) or • patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

human albumin grifols 20%/50ml

grifols malaysia sdn. bhd. - albumin human -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

human albumin grifols 5%100ml

grifols malaysia sdn. bhd. - albumin human -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

human albumin grifols 5%250ml

grifols malaysia sdn. bhd. - albumin human -